Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 414

1.

Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial.

Tomaniak M, Chichareon P, Takahashi K, Kogame N, Modolo R, Chang CC, Spitzer E, Neumann FJ, Plante S, Hernández Antolin R, Jambrik Z, Gelev V, Brunel P, Konteva M, Beygui F, Morelle JF, Filipiak KJ, van Geuns RJ, Soliman O, Tijssen J, Rademaker-Havinga T, Storey RF, Hamm C, Steg PG, Windecker S, Onuma Y, Valgimigli M, Serruys PW.

Eur Heart J Cardiovasc Pharmacother. 2019 Dec 9. pii: pvz052. doi: 10.1093/ehjcvp/pvz052. [Epub ahead of print]

PMID:
31876907
2.

Ticagrelor Monotherapy Beyond One Month after PCI in ACS or Stable CAD in Elderly Patients Aged Above 75 Years: a Prespecified Analysis of the Randomized GLOBAL LEADERS Trial.

Tomaniak M, Chichareon P, Modolo R, Takahashi K, Chang CC, Kogame N, Spitzer E, Buszman PE, van Geuns RM, Valkov V, Steinwender C, Geisler T, Prokopczuk J, Sabaté M, Zmudka K, Rademaker-Havinga T, Tijssen JGP, Jüni P, Hamm C, Steg PG, Onuma Y, Vranckx P, Valgimigli M, Windecker S, Baber U, Anderson R, Dominici M, Serruys PW.

EuroIntervention. 2019 Dec 17. pii: EIJ-D-19-00699. doi: 10.4244/EIJ-D-19-00699. [Epub ahead of print]

3.

Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial.

Takahashi K, Kogame N, Tomaniak M, Chichareon P, Chang CC, Modolo R, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, van Geuns RJ, Dominici M, Huber K, Buszman P, Bolognese L, Tumscitz C, Żmudka K, Aminian A, Vrolix M, Petrov I, Wykrzykowska JJ, de Winter RJ, Hamm C, Steg PG, Onuma Y, Valgimigli M, Windecker S, Vranckx P, Garg S, Serruys PW.

Clin Res Cardiol. 2019 Dec 11. doi: 10.1007/s00392-019-01585-w. [Epub ahead of print]

PMID:
31828504
4.
5.

Effect of Face-to-Face vs Virtual Reality Training on Cardiopulmonary Resuscitation Quality: A Randomized Clinical Trial.

Nas J, Thannhauser J, Vart P, van Geuns RJ, Muijsers HEC, Mol JQ, Aarts GWA, Konijnenberg LSF, Gommans DHF, Ahoud-Schoenmakers SGAM, Vos JL, van Royen N, Bonnes JL, Brouwer MA.

JAMA Cardiol. 2019 Nov 17. doi: 10.1001/jamacardio.2019.4992. [Epub ahead of print]

PMID:
31734702
6.

Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction.

Konijnenberg LSF, Damman P, Duncker DJ, Kloner RA, Nijveldt R, van Geuns RJ, Berry C, Riksen NP, Escaned J, van Royen N.

Cardiovasc Res. 2019 Nov 9. pii: cvz301. doi: 10.1093/cvr/cvz301. [Epub ahead of print]

PMID:
31710673
7.

The impact on radial injury of sheathless versus conventional access for transradial interventions: a randomized trial.

van der Heijden DJ, van Leeuwen MAH, Brinckman SL, Madera Cambero MI, Aipassa T, Vart P, van Geuns RM, van Royen N.

EuroIntervention. 2019 Nov 5. pii: EIJ-D-19-00380. doi: 10.4244/EIJ-D-19-00380. [Epub ahead of print] No abstract available.

8.

Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial).

Chang CC, Spitzer E, Chichareon P, Takahashi K, Modolo R, Kogame N, Tomaniak M, Komiyama H, Yap SC, Hoole SP, Gori T, Zaman A, Frey B, Ferreira RC, Bertrand OF, Koh TH, Sousa A, Moschovitis A, van Geuns RJ, Steg PG, Hamm C, Jüni P, Vranckx P, Valgimigli M, Windecker S, Serruys PW, Soliman O, Onuma Y.

Am J Cardiol. 2019 Dec 15;124(12):1833-1840. doi: 10.1016/j.amjcard.2019.08.049. Epub 2019 Sep 26.

PMID:
31648781
9.

Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease.

Kogame N, Takahashi K, Tomaniak M, Chichareon P, Modolo R, Chang CC, Komiyama H, Katagiri Y, Asano T, Stables R, Fath-Ordoubadi F, Walsh S, Sabaté M, Davies JE, Piek JJ, van Geuns RJ, Reiber JHC, Banning AP, Escaned J, Farooq V, Serruys PW, Onuma Y.

JACC Cardiovasc Interv. 2019 Oct 28;12(20):2064-2075. doi: 10.1016/j.jcin.2019.08.009. Epub 2019 Sep 25.

PMID:
31563682
10.

Intravascular Polarimetry in Patients With Coronary Artery Disease.

Otsuka K, Villiger M, Karanasos A, van Zandvoort LJC, Doradla P, Ren J, Lippok N, Daemen J, Diletti R, van Geuns RJ, Zijlstra F, van Soest G, Dijkstra J, Nadkarni SK, Regar E, Bouma BE.

JACC Cardiovasc Imaging. 2019 Aug 14. pii: S1936-878X(19)30599-6. doi: 10.1016/j.jcmg.2019.06.015. [Epub ahead of print]

11.

Can We Keep Our Young Patients Free From Permanent Metallic Implants?

van Geuns RJ, Pellegrini D, Chang CC, Ten Cate T.

Cardiovasc Revasc Med. 2019 Aug;20(8):640-641. doi: 10.1016/j.carrev.2019.07.006. No abstract available.

PMID:
31420074
12.

Major Infections after Bypass Surgery and Stenting for Multivessel Coronary Disease: An analysis of the randomized SYNTAX trial.

Mancone M, Cavalcante R, Modolo R, Falcone M, Biondi-Zoccai G, Frati G, Spitzer E, Benedetto U, Blackstone EH, Onuma Y, van Geuns RJ, Diletti R, Serruys PW; Collaborators.

EuroIntervention. 2019 Jul 9. pii: EIJ-D-19-00208. doi: 10.4244/EIJ-D-19-00208. [Epub ahead of print]

13.

Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial.

Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang CC, Tomaniak M, Asano T, Katagiri Y, van Geuns RM, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber CK, Sabaté M, Iqbal J, Wykrzykowska JJ, Piek JJ, Spitzer E, Jüni P, Hamm C, Steg PG, Valgimigli M, Vranckx P, Windecker S, Serruys PW.

EuroIntervention. 2019 Aug 9;15(6):e539-e546. doi: 10.4244/EIJ-D-19-00184.

14.

The impact of plaque type on strut embedment/protrusion and shear stress distribution in bioresorbable scaffold.

Torii R, Tenekecioglu E, Katagiri Y, Chichareon P, Sotomi Y, Dijkstra J, Asano T, Modolo R, Takahashi K, Jonker H, van Geuns R, Onuma Y, Pekkan K, Bourantas CV, Serruys PW.

Eur Heart J Cardiovasc Imaging. 2019 Jun 19. pii: jez155. doi: 10.1093/ehjci/jez155. [Epub ahead of print]

PMID:
31215995
15.

Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial.

Chang CC, Onuma Y, Achenbach S, Barbato E, Chevalier B, Cook S, Dudek D, Escaned J, Gori T, Kočka V, Tarantini G, West NEJ, Morice MC, Tijssen JGP, van Geuns RJ, Smits PC; COMPARE ABSORB trial investigators.

Cardiovasc Revasc Med. 2019 Jul;20(7):577-582. doi: 10.1016/j.carrev.2019.04.013. Epub 2019 Apr 16.

16.

Dutch multicenter experience using the STENTYS Xposition S self-apposing stent in complex coronary lesions.

Vlieger S, Simsek C, Balland A, Somi S, Jessurun G, Amoroso G, Kauer F, van Geuns RJ, IJsselmuiden A.

Catheter Cardiovasc Interv. 2019 Dec 1;94(7):966-971. doi: 10.1002/ccd.28192. Epub 2019 Mar 23.

PMID:
30903739
17.

Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY).

Leonardi S, Franzone A, Piccolo R, McFadden E, Vranckx P, Serruys P, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, van Geuns RJ, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Hamm C, Steg G, Heg D, Juni P, Windecker S, Valgimigli M.

BMJ Open. 2019 Mar 9;9(3):e026053. doi: 10.1136/bmjopen-2018-026053.

18.

Bioresorbable Scaffolds and Bifurcations.

van Geuns RJ.

Cardiovasc Revasc Med. 2019 Jan;20(1):4. doi: 10.1016/j.carrev.2018.12.014. No abstract available.

PMID:
30744826
19.

Post-implantation shear stress assessment: an emerging tool for differentiation of bioresorbable scaffolds.

Tenekecioglu E, Torii R, Katagiri Y, Chichareon P, Asano T, Miyazaki Y, Takahashi K, Modolo R, Al-Lamee R, Al-Lamee K, Colet C, Reiber JHC, Pekkan K, van Geuns R, Bourantas CV, Onuma Y, Serruys PW.

Int J Cardiovasc Imaging. 2019 Mar;35(3):409-418. doi: 10.1007/s10554-018-1481-3. Epub 2018 Nov 13.

20.

Predictors of long-term adverse events after Absorb bioresorbable vascular scaffold implantation: a 1,933-patient pooled analysis from international registries.

Caixeta A, Campos CM, Felix C, Chieffo A, Capranzano P, Kawamoto H, Tamburino C, Diletti R, de Ribamar Costa J Jr, Onuma Y, van Geuns RJ, Bartorelli AL, Colombo A, Tamburino C, Serruys PW, Abizaid A.

EuroIntervention. 2019 Sep 20;15(7):623-630. doi: 10.4244/EIJ-D-16-00796.

21.

Prognostic Value of Intravascular Ultrasound in Patients With Coronary Artery Disease.

Schuurman AS, Vroegindewey MM, Kardys I, Oemrawsingh RM, Garcia-Garcia HM, van Geuns RJ, Regar E, Van Mieghem NM, Ligthart J, Serruys PW, Boersma E, Akkerhuis KM.

J Am Coll Cardiol. 2018 Oct 23;72(17):2003-2011. doi: 10.1016/j.jacc.2018.08.2140.

22.

Associations of 26 Circulating Inflammatory and Renal Biomarkers with Near-Infrared Spectroscopy and Long-term Cardiovascular Outcome in Patients Undergoing Coronary Angiography (ATHEROREMO-NIRS Substudy).

Anroedh SS, Akkerhuis KM, Oemrawsingh RM, Garcia-Garcia HM, Brankovic M, Regar E, van Geuns RJ, Serruys PW, Daemen J, van Mieghem NM, Boersma E, Kardys I.

Curr Atheroscler Rep. 2018 Sep 14;20(10):52. doi: 10.1007/s11883-018-0752-8. Review.

23.

Appropriate use criteria for optical coherence tomography guidance in percutaneous coronary interventions : Recommendations of the working group of interventional cardiology of the Netherlands Society of Cardiology.

IJsselmuiden AJJ, Zwaan EM, Oemrawsingh RM, Bom MJ, Dankers FJWM, de Boer MJ, Camaro C, van Geuns RJM, Daemen J, van der Heijden DJ, Jukema JW, Kraaijeveld AO, Meuwissen M, Schölzel BE, Pundziute G, van der Harst P, van Ramshorst J, Dirksen MT, Zivelonghi C, Agostoni P, van der Heyden JAS, Wykrzykowska JJ, Scholte MJ, Nef HM, Kofflard MJM, van Royen N, Alings M, Kedhi E.

Neth Heart J. 2018 Oct;26(10):473-483. doi: 10.1007/s12471-018-1143-z. Review.

24.

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.

Vranckx P, Valgimigli M, Jüni P, Hamm C, Steg PG, Heg D, van Es GA, McFadden EP, Onuma Y, van Meijeren C, Chichareon P, Benit E, Möllmann H, Janssens L, Ferrario M, Moschovitis A, Zurakowski A, Dominici M, Van Geuns RJ, Huber K, Slagboom T, Serruys PW, Windecker S; GLOBAL LEADERS Investigators.

Lancet. 2018 Sep 15;392(10151):940-949. doi: 10.1016/S0140-6736(18)31858-0. Epub 2018 Aug 27.

PMID:
30166073
25.

IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3).

van den Berg VJ, Haskard DO, Fedorowski A, Hartley A, Kardys I, Caga-Anan M, Akkerhuis KM, Oemrawsingh RM, van Geuns RJ, de Jaegere P, van Mieghem N, Regar E, Ligthart JMR, Umans VAWM, Serruys PW, Melander O, Boersma E, Khamis RY.

EBioMedicine. 2018 Oct;36:63-72. doi: 10.1016/j.ebiom.2018.08.023. Epub 2018 Aug 18.

26.

The Tryton® dedicated bifurcation stent: Five-year clinical outcomes.

Green PG, Stella PR, Kumsārs I, Dens J, Sonck J, Bennett J, Bethencourt A, López BR, Dudek D, van Geuns RJ, Ramcharitar S.

Cardiovasc Revasc Med. 2019 Apr;20(4):316-323. doi: 10.1016/j.carrev.2018.06.023. Epub 2018 Jul 4.

PMID:
30037716
27.

Repeatability Assessment of Intravascular Polarimetry in Patients.

Villiger M, Otsuka K, Karanasos A, Doradla P, Ren J, Lippok N, Shishkov M, Daemen J, Diletti R, van Geuns RJ, Zijlstra F, Dijkstra J, van Soest G, Regar E, Nadkarni SK, Bouma BE.

IEEE Trans Med Imaging. 2018 Jul;37(7):1618-1625. doi: 10.1109/TMI.2018.2815979.

28.

SYNTAX score II predicts long-term mortality in patients with one- or two-vessel disease.

Vroegindewey MM, Schuurman AS, Oemrawsingh RM, van Geuns RJ, Kardys I, Ligthart J, Daemen J, Boersma E, Serruys PW, Akkerhuis KM.

PLoS One. 2018 Jul 2;13(7):e0200076. doi: 10.1371/journal.pone.0200076. eCollection 2018.

29.

One-year efficacy and safety of routine prasugrel in patients with acute coronary syndromes treated with percutaneous coronary intervention: results of the prospective rijnmond collective cardiology research study.

Yetgin T, Boersma E, Smits PC, de Vries AG, Huijskens E, Zijlstra F, van der Linden MMJM, van Geuns RJM; CCR Study Investigators.

Neth Heart J. 2018 Aug;26(7-8):393-400. doi: 10.1007/s12471-018-1126-0.

30.

Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI).

Caplice NM, DeVoe MC, Choi J, Dahly D, Murphy T, Spitzer E, Van Geuns R, Maher MM, Tuite D, Kerins DM, Ali MT, Kalyar I, Fahy EF, Khider W, Kelly P, Kearney PP, Curtin RJ, O'Shea C, Vaughan CJ, Eustace JA, McFadden EP.

Am Heart J. 2018 Jun;200:110-117. doi: 10.1016/j.ahj.2018.03.018. Epub 2018 Apr 3.

PMID:
29898838
31.

Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients.

Anroedh S, Hilvo M, Akkerhuis KM, Kauhanen D, Koistinen K, Oemrawsingh R, Serruys P, van Geuns RJ, Boersma E, Laaksonen R, Kardys I.

J Lipid Res. 2018 Sep;59(9):1729-1737. doi: 10.1194/jlr.P081281. Epub 2018 Jun 1.

32.

Mid-term outcomes of the Absorb BVS versus second-generation DES: A systematic review and meta-analysis.

Felix CM, van den Berg VJ, Hoeks SE, Fam JM, Lenzen M, Boersma E, Smits PC, Serruys PW, Onuma Y, van Geuns RJM.

PLoS One. 2018 May 9;13(5):e0197119. doi: 10.1371/journal.pone.0197119. eCollection 2018. Review.

33.

Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis: Multistudy Registry Results.

Ellis SG, Gori T, Serruys PW, Nef H, Steffenino G, Brugaletta S, Munzel T, Feliz C, Schmidt G, Sabaté M, Onuma Y, van Geuns RJ, Gao RL, Menichelli M, Kereiakes DJ, Stone GW, Testa L, Kimura T, Abizaid A.

JACC Cardiovasc Interv. 2018 Apr 9;11(7):638-644. doi: 10.1016/j.jcin.2017.11.042.

34.

SYNTAX score in relation to intravascular ultrasound and near-infrared spectroscopy for the assessment of atherosclerotic burden in patients with coronary artery disease.

Vroegindewey MM, Schuurman AS, Kardys I, Anroedh SS, Oemrawsingh RM, Ligthart J, Garcia-Garcia HM, van Geuns RM, Regar E, Van Mieghem NM, Serruys PW, Boersma E, Akkerhuis M.

EuroIntervention. 2019 Jan 20;14(13):1408-1415. doi: 10.4244/EIJ-D-17-00827.

35.

Impact of Coronary Remodeling on Fractional Flow Reserve.

Collet C, Katagiri Y, Miyazaki Y, Asano T, Sonck J, van Geuns RJ, Andreini D, Bittencourt MS, Kitslaar P, Tenekeciouglu E, Tijssen JGP, Piek JJ, de Winter RJ, Cosyns B, Rogers C, Zarins CK, Taylor C, Onuma Y, Serruys PW.

Circulation. 2018 Feb 13;137(7):747-749. doi: 10.1161/CIRCULATIONAHA.117.031478. No abstract available. Erratum in: Circulation. 2018 Oct 23;138(17):e617.

PMID:
29440200
36.

Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening.

Sorop O, Heinonen I, van Kranenburg M, van de Wouw J, de Beer VJ, Nguyen ITN, Octavia Y, van Duin RWB, Stam K, van Geuns RJ, Wielopolski PA, Krestin GP, van den Meiracker AH, Verjans R, van Bilsen M, Danser AHJ, Paulus WJ, Cheng C, Linke WA, Joles JA, Verhaar MC, van der Velden J, Merkus D, Duncker DJ.

Cardiovasc Res. 2018 Jun 1;114(7):954-964. doi: 10.1093/cvr/cvy038.

37.

Association of stent-induced changes in coronary geometry with late stent failure: Insights from three-dimensional quantitative coronary angiographic analysis.

Zhang BC, Tu SX, Karanasos A, van Geuns RJ, de Jaegere P, Zijlstra F, Regar E.

Catheter Cardiovasc Interv. 2018 Nov 15;92(6):1040-1048. doi: 10.1002/ccd.27520. Epub 2018 Feb 5.

PMID:
29399998
38.

Recurrent Late Bioresorbable Scaffold Thrombosis as a Presenting Symptom of Underlying Cancer.

Leening MJG, Weevers APJD, van Geuns RM, Deckers JW, Levin MD.

J Am Coll Cardiol. 2018 Jan 16;71(2):259-260. doi: 10.1016/j.jacc.2017.10.086. No abstract available.

39.

Coronary Plaque Microstructure and Composition Modify Optical Polarization: A New Endogenous Contrast Mechanism for Optical Frequency Domain Imaging.

Villiger M, Otsuka K, Karanasos A, Doradla P, Ren J, Lippok N, Shishkov M, Daemen J, Diletti R, van Geuns RJ, Zijlstra F, van Soest G, Libby P, Regar E, Nadkarni SK, Bouma BE.

JACC Cardiovasc Imaging. 2018 Nov;11(11):1666-1676. doi: 10.1016/j.jcmg.2017.09.023. Epub 2017 Dec 13.

40.

Right ventricular involvement in cardiac sarcoidosis demonstrated with cardiac magnetic resonance.

Smedema JP, van Geuns RJ, Ainslie G, Ector J, Heidbuchel H, Crijns HJGM.

ESC Heart Fail. 2017 Nov;4(4):535-544. doi: 10.1002/ehf2.12166. Epub 2017 Jun 6.

41.

Qualitative and quantitative evaluation of dynamic changes in non-culprit coronary atherosclerotic lesion morphology: a longitudinal OCT study.

Zhang BC, Karanasos A, Gnanadesigan M, van der Sijde JN, van Ditzhuijzen N, Witberg K, Ligthart J, Diletti R, van Geuns RJ, Dijkstra J, Zijlstra F, van Soest G, Regar E.

EuroIntervention. 2018 Apr 6;13(18):e2190-e2200. doi: 10.4244/EIJ-D-17-00161.

42.

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.

Escaned J, Collet C, Ryan N, De Maria GL, Walsh S, Sabate M, Davies J, Lesiak M, Moreno R, Cruz-Gonzalez I, Hoole SP, Ej West N, Piek JJ, Zaman A, Fath-Ordoubadi F, Stables RH, Appleby C, van Mieghem N, van Geuns RJ, Uren N, Zueco J, Buszman P, Iñiguez A, Goicolea J, Hildick-Smith D, Ochala A, Dudek D, Hanratty C, Cavalcante R, Kappetein AP, Taggart DP, van Es GA, Morel MA, de Vries T, Onuma Y, Farooq V, Serruys PW, Banning AP.

Eur Heart J. 2017 Nov 7;38(42):3124-3134. doi: 10.1093/eurheartj/ehx512. Erratum in: Eur Heart J. 2018 May 7;39(18):1619.

43.

Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis.

Smedema JP, van Geuns RJ, Ector J, Heidbuchel H, Ainslie G, Crijns HJGM.

ESC Heart Fail. 2018 Feb;5(1):157-171. doi: 10.1002/ehf2.12201. Epub 2017 Oct 2.

44.

The European Collaborative Project on Inflammation and Vascular Wall Remodeling in Atherosclerosis - Intravascular Ultrasound (ATHEROREMO-IVUS) study.

de Boer S, Baran Y, Garcia-Garcia HM, Eskin I, Lenzen MJ, Kleber ME, Regar E, de Jaegere PJ, Ligthart JM, van Geuns RJ, Lehtimäki T, Laaksonen R, Boersma E, Marz W, Halperin E, Serruys PW, Koenig W.

EuroIntervention. 2018 Jun 20;14(2):194-203. doi: 10.4244/EIJ-D-17-00180.

45.

Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study.

Fam JM, Felix C, Ishibashi Y, Onuma Y, Diletti R, Van Mieghem NM, Regar E, De Jaegere P, Zijlstra F, van Geuns RJM.

Int J Cardiol. 2017 Dec 15;249:119-126. doi: 10.1016/j.ijcard.2017.08.046. Epub 2017 Aug 25.

46.

Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold Thrombosis.

Ellis SG, Steffenino G, Kereiakes DJ, Stone GW, van Geuns RJ, Abizaid A, Nef H, Cortese B, Testa L, Menichelli M, Tamburino C, Gori T, Kimura T, Serruys PW, Brugaletta S, Sabaté M, Gao RL.

JACC Cardiovasc Interv. 2017 Sep 25;10(18):1809-1815. doi: 10.1016/j.jcin.2017.06.067.

47.

Serial 5-Year Evaluation of Side Branches Jailed by Bioresorbable Vascular Scaffolds Using 3-Dimensional Optical Coherence Tomography: Insights From the ABSORB Cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).

Onuma Y, Grundeken MJ, Nakatani S, Asano T, Sotomi Y, Foin N, Ng J, Okamura T, Wykrzykowska JJ, de Winter RJ, van Geuns RJ, Koolen J, Christiansen EH, Whitbourn R, McClean D, Smits P, Windecker S, Ormiston JA, Serruys PW.

Circ Cardiovasc Interv. 2017 Sep;10(9). pii: e004393. doi: 10.1161/CIRCINTERVENTIONS.116.004393. Erratum in: Circ Cardiovasc Interv. 2018 Jan;11(1):e000031. Christiansen, Evald [corrected to Christiansen, Evald H].

PMID:
28893770
48.

One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study.

Grundeken MJ, Lu H, Vos N, IJsselmuiden A, van Geuns RJ, Wessely R, Dengler T, La Manna A, Silvain J, Montalescot G, Spaargaren R, Tijssen JGP, de Winter RJ, Wykrzykowska JJ, Amoroso G, Koch KT.

J Invasive Cardiol. 2017 Aug;29(8):253-258.

49.

Development and validation of a risk model for long-term mortality after percutaneous coronary intervention: The IDEA-BIO Study.

van Boven N, van Domburg RT, Kardys I, Umans VA, Akkerhuis KM, Lenzen MJ, Valgimigli M, Daemen J, Zijlstra F, Boersma E, van Geuns RJ.

Catheter Cardiovasc Interv. 2018 Mar 1;91(4):686-695. doi: 10.1002/ccd.27182. Epub 2017 Jul 14.

PMID:
28707322
50.

Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions.

Fam JM, Ishibashi Y, Felix C, Zhang BC, Diletti R, van Mieghem N, Regar E, van Domburg R, Onuma Y, van Geuns RJ.

Int J Cardiovasc Imaging. 2017 Dec;33(12):1863-1871. doi: 10.1007/s10554-017-1193-0. Epub 2017 Jul 6.

Supplemental Content

Loading ...
Support Center